Rachel Miller
🏛️ Revolving DoorFormer Government Positions:
Legislative Assistant, Senator Dianne Feinstein; Legislative Assistant Rep. Elliot Engel
Legislative Assistant, Sen. Dianne Feinstein (2003-2007); Legislative Assistant, Rep. Eliot Engel (2000-2003)
Legislative Assistant, Sen. Dianne Feinstein (2003-2007)
🤖
AI Overview
Rachel Miller has appeared in 2,917 federal lobbying filings at Forbes-tate, representing 50 clients. As a former government official, they bring insider expertise to their lobbying work — part of Washington's "revolving door." Active across 46 policy areas.
2,917
Total Filings
1
Firms
50
Clients
46
Issue Areas
Issue Areas
Filing History
| Year | Filings | Clients |
|---|---|---|
| 2018 | 207 | 21 |
| 2019 | 293 | 24 |
| 2020 | 408 | 29 |
| 2021 | 523 | 37 |
| 2022 | 448 | 33 |
| 2023 | 369 | 34 |
| 2024 | 315 | 27 |
| 2025 | 354 | 29 |
Firms
Forbes-tate2917 filings
Top Clients
American Honda Motor Co., INC.255 filings
A.o. Smith Corporation199 filings
Pacific Gas and Electric124 filings
Entergy Services LLC116 filings
Tyson Shared Services, INC.108 filings
Joby Aviation104 filings
Siemens Corporation103 filings
CEO Climate Dialogue100 filings
Public Service Company of New Mexico91 filings
New Venture Fund87 filings
Public Service Enterprise Group72 filings
The Williams Companies, INC.64 filings
California Life Sciences Association63 filings
Exelon Corporation63 filings
Northwestern Energy60 filings
University of Southern California59 filings
Bipartisan Policy Center Action58 filings
Related Analysis
Related Investigations
The Revolving Door Exposed
How former government officials become the most powerful lobbyists.
Follow the Money
Tracking lobbying dollars through the financial system.
The 22,000% ROI
When lobbying spending yields outsized returns.
The 2025 Tariff Panic
As tariffs return, lobbying on trade surges.
Big Tech's $150M Lobbying War
Tech giants battle over AI, antitrust, privacy, and trade.
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.